48,868
edits
Difference between revisions of "ALK translocation renal cell carcinoma"
Jump to navigation
Jump to search
ALK translocation renal cell carcinoma (view source)
Revision as of 17:50, 17 March 2019
, 17:50, 17 March 2019no edit summary
(tweak) |
|||
| Line 7: | Line 7: | ||
==Microscopic== | ==Microscopic== | ||
Features: | Features: | ||
*Mix of morphologies - rhabdoid, sarcomatoid, "[[unclassified renal cell carcinoma]]". | *Mix of morphologies - rhabdoid, sarcomatoid, "[[unclassified renal cell carcinoma]]", [[papillary renal cell carcinoma]]. | ||
DDx: | DDx: | ||
*[[Unclassified renal cell carcinoma]] | *[[Unclassified renal cell carcinoma]] | ||
*[[Renal medullary carcinoma]]. | *[[Renal medullary carcinoma]]. | ||
*[[Papillary renal cell carcinoma]].<ref namd=pmid29685646>{{Cite journal | last1 = Pal | first1 = SK. | last2 = Bergerot | first2 = P. | last3 = Dizman | first3 = N. | last4 = Bergerot | first4 = C. | last5 = Adashek | first5 = J. | last6 = Madison | first6 = R. | last7 = Chung | first7 = JH. | last8 = Ali | first8 = SM. | last9 = Jones | first9 = JO. | title = Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma. | journal = Eur Urol | volume = 74 | issue = 1 | pages = 124-128 | month = 07 | year = 2018 | doi = 10.1016/j.eururo.2018.03.032 | PMID = 29685646 }}</ref> | |||
==IHC== | ==IHC== | ||